Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7090932 | 0.91 | LMNA (0.59) | LMNAGAAMAPK1CYP3A4FAAH | |
| SCHEMBL11708911 | 0.86 | LMNA (0.67) | LMNAGAAALDH1A1KMT2AACHE | |
| SCHEMBL15763956 | 0.86 | LMNA (0.53) | LMNAGAACYP3A4FAAHALDH1A1 | |
| SCHEMBL9736780 | 0.85 | LMNA (0.65) | LMNAGAAKMT2AACHEMAPT | |
| SCHEMBL7980728 | 0.85 | LMNA (0.65) | LMNAGAAKMT2AACHEMAPT | |
| SCHEMBL20335031 | 0.85 | LMNA (0.65) | LMNAGAAMAPK1CYP3A4FAAH | |
| SCHEMBL11599866 | 0.85 | LMNA (0.65) | LMNAGAAMAPK1CYP3A4FAAH | |
| SCHEMBL10722743 | 0.84 | LMNA (0.59) | LMNAGAAMAPK1CYP3A4FAAH | |
| SCHEMBL819332 | 0.83 | LMNA (0.74) | LMNAGAAMAPK1CYP3A4FAAH | |
| SCHEMBL7922562 | 0.83 | LMNA (0.74) | LMNAGAAMAPK1CYP3A4FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043596-B2 | Thermochromic pigment compositions | SOCIETE BIC (FR) | 2024-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043596-B2 | Thermochromic pigment compositions | TYR, MITF, CRY2 | LMNA 3184/4885GAA 4191/4885MAPK1 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.